Profile for European Patent Office Patent: 1611115
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2015 00009 | ⤷ Start Trial |
| Netherlands | C300724 | ⤷ Start Trial |
| France | 15C0005 | ⤷ Start Trial |
| Estonia | C20150004 00139 | ⤷ Start Trial |
| Luxembourg | 92634 | ⤷ Start Trial |
| Slovakia | 193 5003-2015 | ⤷ Start Trial |
| Sweden | 1590010-3 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 1611115
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
